These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 33390810)

  • 1. DCs-based therapies: potential strategies in severe SARS-CoV-2 infection.
    Han J; Sun J; Zhang G; Chen H
    Int J Med Sci; 2021; 18(2):406-418. PubMed ID: 33390810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection.
    Chang T; Yang J; Deng H; Chen D; Yang X; Tang ZH
    Front Immunol; 2022; 13():843342. PubMed ID: 35265087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2-mediated immune system activation and potential application in immunotherapy.
    Tan Y; Tang F
    Med Res Rev; 2021 Mar; 41(2):1167-1194. PubMed ID: 33185926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.
    Saadeldin MK; Abdel-Aziz AK; Abdellatif A
    Med Hypotheses; 2021 Jan; 146():110365. PubMed ID: 33221134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies.
    Zhou YW; Xie Y; Tang LS; Pu D; Zhu YJ; Liu JY; Ma XL
    Signal Transduct Target Ther; 2021 Aug; 6(1):317. PubMed ID: 34446699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
    Borges RC; Hohmann MS; Borghi SM
    Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity.
    Mi Y; Liang L; Xu K; Li Q; Wang W; Dang W; Deng J; Zhi Y; Li X; Tan J
    Front Cell Infect Microbiol; 2022; 12():986350. PubMed ID: 36439228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.
    Galati D; Zanotta S; Capitelli L; Bocchino M
    Allergy; 2022 Jan; 77(1):100-110. PubMed ID: 34245591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dendritic cells in COVID-19 infection.
    Wang X; Guan F; Miller H; Byazrova MG; Cndotti F; Benlagha K; Camara NOS; Lei J; Filatov A; Liu C
    Emerg Microbes Infect; 2023 Dec; 12(1):2195019. PubMed ID: 36946172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the recent findings of cell-based therapies for the treatment and management of COVID-19.
    Ghaffari S; Kazerooni H; Salehi-Najafabadi A
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108226. PubMed ID: 34634685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses and therapies against SARS-CoV-2 infection.
    Toor SM; Saleh R; Sasidharan Nair V; Taha RZ; Elkord E
    Immunology; 2021 Jan; 162(1):30-43. PubMed ID: 32935333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell vaccine as a potential strategy to end the COVID-19 pandemic. Why should it be
    Jonny J; Putranto TA; Sitepu EC; Irfon R
    Expert Rev Vaccines; 2022 Aug; 21(8):1111-1120. PubMed ID: 35593184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues.
    Cai G; Du M; Bossé Y; Albrecht H; Qin F; Luo X; Androulakis XM; Cheng C; Nagarkatti M; Nagarkatti P; Christiani DC; Whitfield ML; Amos CI; Xiao F
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
    Uraki R; Imai M; Ito M; Shime H; Odanaka M; Okuda M; Kawaoka Y; Yamazaki S
    PLoS Pathog; 2021 Dec; 17(12):e1010085. PubMed ID: 34882757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune system view of the coronavirus SARS-CoV-2.
    Celardo I; Pace L; Cifaldi L; Gaudio C; Barnaba V
    Biol Direct; 2020 Dec; 15(1):30. PubMed ID: 33371901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.
    Fung TS; Liu DX
    Annu Rev Microbiol; 2021 Oct; 75():19-47. PubMed ID: 33492978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
    Silva TF; Tomiotto-Pellissier F; Sanfelice RA; Gonçalves MD; da Silva Bortoleti BT; Detoni MB; Rodrigues ACJ; Carloto ACM; Concato VM; Siqueira EDS; Costa IN; Pavanelli WR; Conchon-Costa I; Miranda-Sapla MM
    Front Immunol; 2020; 11():562264. PubMed ID: 33193331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern Recognition Proteins: First Line of Defense Against Coronaviruses.
    Labarrere CA; Kassab GS
    Front Immunol; 2021; 12():652252. PubMed ID: 34630377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.